Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by ENDRA Life Sciences Inc.
< Previous
1
2
3
Next >
ASP Isotopes Announces Proposed Merger of Noble Africa with ENDRA Life Sciences and Approximately $50 Million Concurrent Private Placement Financing
June 25, 2026
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
ASPI
NDRA
ENDRA Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update
May 18, 2026
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Reports Multi-Site Validation of TAEUS® Liver Device Demonstrating MRI-like Accuracy and Reproducibility
May 14, 2026
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
March 31, 2026
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder Value
March 25, 2026
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA’s TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care
February 26, 2026
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA’s TAEUS® Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use
December 04, 2025
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Feasibility Study Demonstrates TAEUS® Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker
November 20, 2025
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Recaps Major Milestones and New Strategic Initiatives, Announces Third Quarter 2025 Financial Results
November 17, 2025
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Commences Staking of HYPE Digital Asset Holdings, Reinforcing Long-Term Strategy with Anchorage Digital and ARCA
November 13, 2025
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Closes Up to $14.4 Million Private Placement and Launches Crypto Treasury Strategy with $3 Million in Initial HYPE Token Holdings
October 23, 2025
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Announces At-Market Private Placement of Up to $14.4 Million to Launch Digital Asset Treasury Strategy Managed by Leading Crypto Asset Manager Arca
October 13, 2025
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Provides a Business Update and Reports Second Quarter 2025 Financial Results
August 14, 2025
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA’s Ongoing Multisite Pilot Study Reveals Important Enhancements to Boost TAEUS Liver Accuracy and Repeatability Against MRI Gold Standard
June 16, 2025
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Provides a Business Update and Reports First Quarter 2025 Financial Results
May 15, 2025
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Announces Enhanced Strategy to Enable the Early Detection and Management of Metabolic Diseases Facilitated by Emerging GLP-1 Therapies
March 31, 2025
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Business Update
March 31, 2025
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement
November 22, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update
November 15, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
Study Highlighting ENDRA Life Sciences’ TAEUS Technology in Patients with High BMI to be Presented at AASLD’s The Liver Meeting® 2024
November 12, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Further Strengthens TAEUS® Platform Intellectual Property with Issuance of 17th European Patent
November 06, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in Germany
October 22, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirements
August 28, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business Update
August 22, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Announces Reverse Stock Split
August 16, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Reschedules Second Quarter Conference Call to August 22, 2024
August 13, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Announces Leadership Changes
August 13, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences to Report Second Quarter 2024 Financial Results on August 14
August 07, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering
June 04, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Provides Update Following In-person Meeting with FDA
May 20, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit